Today's top medical abstracts
Endocrinology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Endocrinology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Endocrinology
        Adrenal Glands
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Bone Metabolism
        Diabetes
        Diagnostics
        Economics of Medicine
        Endocrine Oncology
        Fetal Development
        Hypertension
        Metabolism and Growth
        Neuroendocrinology
        Obesity
        Pediatric Endocrinology
        Pharmacology/kinetics
        Popular Press
        Primary Care
        Reproductive
    Endocrinology
        Thyroid/Parathyroid
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
FDA Update: Thyrotropin Approved For Thyroid Cancer Ablation
Tracy Hampton, PhD, MDLinx Oncology
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas
Modern Pathology, 05/16/08
Print     Email This Article     Save in My Library   Free Abstract
Yuan YF et al. - In a study to evaluate the π-class glutathione-S-transferase (GSTP1) expression level and GSTP1 DNA methylation status in a series of pituitary adenomas, it was shown that GSTP1 inactivation through CpG hypermethylation is common in pituitary adenomas and may contribute to aggressive pituitary tumor behavior

Methods
  • Using immunohistochemistry, expression of GSTP1 was identified in all of the various normal hormone-producing adenohypophysial cell types

Results
  • In pituitary adenomas, loss or reduced expression of GSTP1 was detected in 27 of 53 tumors
  • Expression of GSTP1 was significantly lower in invasive adenomas than in noninvasive adenomas
  • Using methylation-specific polymerase chain reaction (MS-PCR), GSTP1 DNA promoter hypermethylation was detected in adenomas but not in normal tissues
  • GSTP1 methylation was more frequent in grade II, III, and IV tumors than in grade I tumors
  • Frequency of GSTP1 methylation was higher in invasive tumors than in noninvasive tumors
  • Methylation status correlated with significant downregulation of GSTP1 expression; the frequency of GSTP1 methylation was higher in tumors with reduced-GSTP1 expression than in tumors with normal or high GSTP1 expression

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.